IMNN Imunon
- 1.450
- -0.060-3.97%
Imunon News
IMUNON Appoints Stacy R. Lindborg As President And CEO, Effective May 13, 2024
Assumes leadership role as Company anticipates multiple near-term clinical milestonesBrings extensive leadership and experience in drug development and business strategyLAWRENCEVILLE, N.J., May 08, 20
IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
PDF Version Assumes leadership role as Company anticipates multiple near-term clinical milestonesBrings extensive leadership and experience in drug development and business strategyLAWRENCEVILLE,
IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024
PDF Version LAWRENCEVILLE, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and nex
Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine
By Chris Wack Imunon shares rose after the company received clearance from the U.S. Food and Drug Administration to begin a Phase 1 clinical trial with a seasonal Covid-19 booster vaccine. Shares we
IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101
PDF Version Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarterLAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IM
IMUNON Reports Compliance With Nasdaq Listing Requirements
PDF Version LAWRENCEVILLE, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN) ("IMUNON" or the "Company"), a clinical-stage drug-development company focused on developing DNA-
Imunon Withdraws Filing for Securities Offering
Imunon Withdraws Filing for Securities Offering
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersProtara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday's pre-market session. The market value of their outstanding shares is at $64.4 million. Candel Therapeutics (N
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersOneMedNet (NASDAQ:ONMD) shares moved upwards by 75.9% to $1.39 during Tuesday's after-market session. The market value of their outstanding shares is at $44.8 million. Aesthetic Medical Intl (N
Imunon Is Maintained at Buy by HC Wainwright & Co.
Imunon Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Imunon, Raises Price Target to $13
HC Wainwright & Co. analyst Emily Bodnar maintains Imunon (NASDAQ:IMNN) with a Buy and raises the price target from $12 to $13.
Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Imunon (IMNN)
Top Midday Gainers
Avalo Therapeutics (AVTX) shares skyrocketed amid heavy trading Thursday after the company completed the acquisition of privately held AlmataBio and said late Wednesday it entered into a private place
Earnings Call Summary | Imunon(IMNN.US) Q4 2023 Earnings Conference
The following is a summary of the Imunon, Inc. (IMNN) Q4 2023 Earnings Call Transcript:Financial Performance:Imunon ended 2023 with $15.7 million in cash and investments.The company used $18.9 million
Imunon Says $15.7M In Cash, Investments, And Accrued Interest Receivable And Future Planned Sales Of The Company's Remaining $1.3M Of New Jersey NOLS, Is Expected to Provide Cash Runway Into Q4 2024
Imunon Says $15.7M In Cash, Investments, And Accrued Interest Receivable And Future Planned Sales Of The Company's Remaining $1.3M Of New Jersey NOLS, Is Expected to Provide Cash Runway Into Q4 2024
Imunon GAAP EPS of -$2.16 Beats by $0.07
Imunon Believes It Has Sufficient Cap Resources to Fund Its Ops Into the 4Q of 2024 >IMNN
Imunon Believes It Has Sufficient Cap Resources to Fund Its Ops Into the 4Q of 2024 >IMNN
Imunon Ended 2023 With $15.7M in Cash, Investments and Accrued Interest Receivable >IMNN
Imunon Ended 2023 With $15.7M in Cash, Investments and Accrued Interest Receivable >IMNN
Imunon FY23 Loss/Shr $2.16 >IMNN
Imunon FY23 Loss/Shr $2.16 >IMNN
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. • Shimmick (NASDAQ:SHIM) is estimated
Analysis
Price Target
No Data
